共 3 条
Click-Chemistry Strategy for Labeling Antibodies with Copper-64 via a Cross-Bridged Tetraazamacrocyclic Chelator Scaffold
被引:17
|作者:
Kumar, Amit
[1
]
Hao, Guiyang
[1
]
Liu, Li
[1
]
Ramezani, Saleh
[1
]
Hsieh, Jer-Tsong
[2
]
Oz, Orhan K.
[1
]
Sun, Xiankai
[1
,3
]
机构:
[1] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA
[2] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA
[3] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA
基金:
美国国家卫生研究院;
关键词:
IN-VIVO;
BIFUNCTIONAL CHELATOR;
PROSTATE-CANCER;
PEPTIDE;
CU-64;
RADIOPHARMACEUTICALS;
RADIOTHERAPY;
XENOGRAFTS;
EXPRESSION;
COMPLEXES;
D O I:
10.1021/acs.bioconjchem.5b00102
中图分类号:
Q5 [生物化学];
学科分类号:
071010 ;
081704 ;
摘要:
We report a click-chemistry based modular strategy for antibody labeling with Cu-64 (t(1/2) = 12.7 h; beta+ 0.656 MeV, 17.4%; beta 0.573 MeV, 39%; EC 43%) under ambient condition utilizing a cross-bridged tetraazamacrocyclic (CB-TE2A) analogue, which otherwise requires harsh conditions that make the CB-TE2A analogues under-utilized for protein labeling despite the fact that they form kinetically inert copper complexes with high in vivo stability. Our strategy involves prelabeling a CB-TE2A based scaffold (CB-TE2A-1C) with Cu-64 and its subsequent reaction with an antibody via the tetrazine-norbornene mediated click chemistry. The effectiveness of this strategy was demonstrated by labeling two monoclonal antibodies, an anti-PSMA antibody (YPSMA-1) and a chimeric anti-phosphatidylserine antibody (Bavituximab). The immunoreactivity of the antibodies remained unchanged after the tetrazine modification and click-chemistry Cu-64 labeling. To further demonstrate the practicality of the modular Cu-64 labeling strategy, we tested positron emission tomography (PET) imaging of tumor with the Cu-64-labeled bavituximab in a mouse xenograft model. The tumor visualization and uptake of the labeled antibody exhibited the versatility of the click-chemistry strategy.
引用
收藏
页码:782 / 789
页数:8
相关论文